PATHOGENETICALLY TARGETED THERAPY FOR GASTROESOPHAGEAL REFLUX DISEASE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper provides evidence that pathogenetically targeted therapy with a combination of a proton pump inhibitor and an alginate (Gaviscon® Double Action) should be used in gastroesophageal reflux disease.

Full Text

Restricted Access

About the authors

B. Starostln

City Clinical Polyclinic Thirty-Eight

Email: borstar56@yandex.ru
Saint Petersburg

References

  1. Старостин Б.Д. Гастроэзофагеальная рефлюксная болезнь (часть I). Эпидемиология, факторы риска // Гастроэнтерология Санкт-Петербурга. -2014; 1-2: 2-14.
  2. Kahrilas P. Gastroesophageal reflux disease // JAMA. - 1996; 276: 983-8.
  3. Старостин Б.Д. Гастроэзофагеальная рефлюксная болезнь // Рус. мед. журн. - 1997; 5 (2): 72-80.
  4. Исаков В.А., Морозов С.В., Ставраки Е.С. и др. Анализ распространенности изжоги: национальное эпидемиологическое исследование взрослого городского населения (АРИАДНА) // Экспер. и клин. гастроэнтерол. - 2008; 1: 20-9.
  5. Лазебник Л.Б., Машарова А.А., Бордин Д.С. и др. Результаты многоцентрового исследования «Эпидемиология гастроэзофагеальной рефлюксной болезни в России» (МЭГРЕ) // Тер. арх. - 2011; 16: 45-50.
  6. Старостин Б.Д. Гастроэзофагеальная рефлюксная болезнь (часть II). Этиопатогенез, клиника, диагностика // Гастроэнтерология Санкт-Петербурга. - 2014; 3-4: 2-14.
  7. Tytgat G., McColl K., Tack J. et al. New algorithm for the treatment of gastro-oesophageal reflux disease // Aliment. Pharmacol. Ther. - 2008; 27: 249-56.
  8. Fletcher J. et al. Unbuffered Highly Acidic Gastric Juice Exists at the Gastroesophageal Junction After a Meal // Gastroenterology. - 2001; 121: 77583.
  9. Beamont H., Bennink R., de Jong J. et al. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD // Gut. - 2010; 59 (4): 441-51.
  10. Namasiovayam V., Katzka D. Extraesophageal reflux Definition and Pathophysiology. In: AJ DiMarino Jr, S. Cohen, ed. Extraesophageal Manifestations of GERD. Slack Incorporated, 2013; 1-19.
  11. Clarke A., Wirz A., Manning J. et al. Severe reflux disease is associated with an enlarged unbuffered proximal gastric acid pocket // Gut. - 2008; 57: 292-7.
  12. Pandolfino J. et al. Acidity Surrounding the Squamocolumnar Junction in GERD Patients: «Acid Pocket» Versus «Acid Film» // Am. J. Gastroenterol. - 2007; 102: 263-4.
  13. Kahrilas P. et al. The Acid Pocket: A Target for Treatment in Reflux Disease? // Am. J. Gastroenterol. - 2013; 108: 1058-64.
  14. Beaumont H., Boeckxstaens G. Scintigraphic imaging of the acid pocket: an enlarged pocket with acid coating the distal esophagus in GERD patients with hiatal hernia. 2009.
  15. Kahrilas P., Boeckxstaens G., Smout A. Management of the patient with incomplete response to PPI therapy // Best Practice & Res. Clin. Gastroenterol. -2013; 27: 401-14.
  16. Manabe N., Haruma K., Ito M. et al. Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial // Dis. Esophagus. - 2012; 25: 373-80.
  17. Chiu C.-T. et al. Randomised clinical trial: sodium alginate oral suspension is non-inferior to omeprazole in the treatment of patients with non-erosive gastroesophageal disease // Aliment. Pharmacol. Ther. - 2013; 38 (9): 1054-64.
  18. Wang Y.-K. et al. Current Pharmacological Management of Gastroesophageal Reflux Disease // Gastroenterol Res. Pract. - 2013; http://dx.doi.org/10.1155/2013/983653
  19. Boeckxstaens G. et al. Symptomatic reflux disease: the present, the past and the future // Gut. - 2014; 63: 1185-93.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2015 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies